These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9851440)

  • 1. Vigabatrin increases human brain homocarnosine and improves seizure control.
    Petroff OA; Mattson RH; Behar KL; Hyder F; Rothman DL
    Ann Neurol; 1998 Dec; 44(6):948-52. PubMed ID: 9851440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-term vigabatrin therapy on selected neurotransmitter concentrations in cerebrospinal fluid.
    Ben-Menachem E; Persson LI; Mumford J; Haegele KD; Huebert N
    J Child Neurol; 1991; Suppl 2():S11-6. PubMed ID: 1719063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
    Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
    Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain homocarnosine and seizure control of patients taking gabapentin or topiramate.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2006 Mar; 47(3):495-8. PubMed ID: 16529611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
    Petroff OA; Behar KL; Mattson RH; Rothman DL
    J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy.
    Petroff OA; Hyder F; Mattson RH; Rothman DL
    Neurology; 1999 Feb; 52(3):473-8. PubMed ID: 10025774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
    Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
    Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocarnosine and the measurement of neuronal pH in patients with epilepsy.
    Rothman DL; Behar KL; Prichard JW; Petroff OA
    Magn Reson Med; 1997 Dec; 38(6):924-9. PubMed ID: 9402193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2000 Jun; 41(6):675-80. PubMed ID: 10840398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized 1H NMR measurements of 2-pyrrolidinone in human brain in vivo.
    Hyder F; Petroff OA; Mattson RH; Rothman DL
    Magn Reson Med; 1999 May; 41(5):889-96. PubMed ID: 10332870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate rapidly raises brain GABA in epilepsy patients.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Epilepsia; 2001 Apr; 42(4):543-8. PubMed ID: 11440351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
    Petroff OA; Rothman DL
    Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
    Ben-Menachem E; Persson LI; Schechter PJ; Haegele KD; Huebert N; Hardenberg J; Dahlgren L; Mumford JP
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low brain GABA level is associated with poor seizure control.
    Petroff OA; Rothman DL; Behar KL; Mattson RH
    Ann Neurol; 1996 Dec; 40(6):908-11. PubMed ID: 9007096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures.
    Petroff OA; Hyder F; Rothman DL; Mattson RH
    Neurology; 2001 Mar; 56(6):709-15. PubMed ID: 11274303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vigabatrin--a new antiepileptic agent].
    Nakken KO; Henriksen O; Johannessen SI
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2843-4. PubMed ID: 7998031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy.
    Petroff OA; Rothman DL; Behar KL; Lamoureux D; Mattson RH
    Ann Neurol; 1996 Jan; 39(1):95-9. PubMed ID: 8572673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ; Ylinen A; Halonen T; Sivenius J; Pitkanen A
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea.
    Bonnet AM; Tell G; Schechter PJ; Grove J; Saint-Hilaire MH; De Smet Y; Agid Y
    Mov Disord; 1987; 2(2):117-23. PubMed ID: 2973560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.